CLINICAL_TRIALS
trial_result
· 2021-10-07
Clinical Trial Update: Effects of Sodium Pyruvate Nasal Spray in COVID-19 Long Haulers. [Phase 2, Phase 3]
Summary
Phase 2/3 trial assessing effects of sodium pyruvate nasal spray for Long COVID, with completed status and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cellular Sciences, inc. | Conditions: Long COVID | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2021-10-07